Cisplatin-refractory, HER2/neu-expressing germ-cell cancer: Induction of remission by the monoclonal antibody Trastuzumab

被引:46
作者
Kollmannsberger, C [1 ]
Pressler, H
Mayer, F
Kanz, L
Bokemeyer, C
机构
[1] Univ Tuebingen, Med Ctr, Dept Hematol Oncol, Tubingen, Germany
[2] Univ Tubingen, Dept Pathol, Tubingen, Germany
关键词
D O I
10.1023/A:1008365216323
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1393 / 1394
页数:3
相关论文
共 3 条
[1]  
BOKEMEYER C, 1999, IN PRESS INT J CANC
[2]  
Henley J, 1999, P AN M AM SOC CLIN, V18, p341a
[3]   A subclass of tumor-inhibitory monoclonal antibodies to ErbB-2/HER2 blocks crosstalk with growth factor receptors [J].
Klapper, LN ;
Vaisman, N ;
Hurwitz, E ;
PinkasKramarski, R ;
Yarden, Y ;
Sela, M .
ONCOGENE, 1997, 14 (17) :2099-2109